Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1972 1
1973 1
1975 1
1982 1
1987 1
1988 1
1990 7
1991 3
1992 2
1993 1
1994 1
1995 1
1996 1
1997 1
1998 3
1999 2
2000 2
2001 1
2002 1
2004 3
2005 2
2006 4
2007 5
2008 2
2009 3
2010 3
2011 3
2013 3
2014 1
2015 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 21624883

59 results
Results by year
Filters applied: . Clear all
Page 1
Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.
Bryant KA, Marshall GS, Marchant CD, Pavia-Ruiz N, Nolan T, Rinderknecht S, Blatter M, Aris E, Lestrate P, Boutriau D, Friedland LR, Miller JM. Bryant KA, et al. Pediatrics. 2011 Jun;127(6):e1375-85. doi: 10.1542/peds.2009-2992. Epub 2011 May 29. Pediatrics. 2011. PMID: 21624883 Clinical Trial.
Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, Boutriau D; HibMenCY-TT 005 Study Group. Marchant CD, et al. Pediatr Infect Dis J. 2010 Jan;29(1):48-52. doi: 10.1097/INF.0b013e3181c3ce88. Pediatr Infect Dis J. 2010. PMID: 20035207 Clinical Trial.
Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B, Wald E, Guerra N, Byers C. Dashefsky B, et al. Pediatrics. 1990 Apr;85(4 Pt 2):682-9. Pediatrics. 1990. PMID: 2107519 Clinical Trial.
A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, Poolman J, Boutriau D. Nolan T, et al. Vaccine. 2007 Dec 12;25(51):8487-99. doi: 10.1016/j.vaccine.2007.10.013. Epub 2007 Oct 25. Vaccine. 2007. PMID: 17996996 Clinical Trial.
The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D. Gatchalian S, et al. Int J Infect Dis. 2008 May;12(3):278-88. doi: 10.1016/j.ijid.2007.08.007. Epub 2007 Nov 5. Int J Infect Dis. 2008. PMID: 17981067 Free article. Clinical Trial.
Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age.
Marshall GS, Blatter M, Marchant C, Aris E, Mesaros N, Miller JM. Marshall GS, et al. Pediatr Infect Dis J. 2013 Jun;32(6):662-8. doi: 10.1097/INF.0b013e3182840e35. Pediatr Infect Dis J. 2013. PMID: 23340564 Clinical Trial.
Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine.
Nolan T, Richmond P, Marshall H, McVernon J, Alexander K, Mesaros N, Aris E, Miller J, Poolman J, Boutriau D. Nolan T, et al. Pediatr Infect Dis J. 2011 Mar;30(3):190-6. doi: 10.1097/INF.0b013e3181fcb2bf. Pediatr Infect Dis J. 2011. PMID: 20948453 Clinical Trial.
Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Yogev R, et al. Pediatrics. 1990 Apr;85(4 Pt 2):690-3. Pediatrics. 1990. PMID: 2107520 Clinical Trial.
Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM. Lottenbach KR, et al. J Am Geriatr Soc. 2004 Nov;52(11):1883-7. doi: 10.1111/j.1532-5415.2004.52511.x. J Am Geriatr Soc. 2004. PMID: 15507066 Clinical Trial.
The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M, Wolff M, Reid R, Hohenboken M, Bateman M, Goepp J, Cortese M, Sack D, Hill J, Newcomer W, et al. Santosham M, et al. N Engl J Med. 1991 Jun 20;324(25):1767-72. doi: 10.1056/NEJM199106203242503. N Engl J Med. 1991. PMID: 1903846 Free article. Clinical Trial.
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback